CN Patent

CN113631159A — 带有局部麻醉剂的自固化局部制剂

Assigned to Kedi Biomedical Wuxi Co ltd · Expires 2021-11-09 · 5y expired

What this patent protects

本发明提供一种自固化局部制剂，所述自固化局部制剂包括6重量％至8重量％的利多卡因、6重量％至8重量％的丁卡因、约0.5重量％至约15重量％的成膜悬浮剂、在25℃下具有至少30％(以重量计)的溶解度的成膜填料、以及约25重量％至约75重量％的水。

USPTO Abstract

本发明提供一种自固化局部制剂，所述自固化局部制剂包括6重量％至8重量％的利多卡因、6重量％至8重量％的丁卡因、约0.5重量％至约15重量％的成膜悬浮剂、在25℃下具有至少30％(以重量计)的溶解度的成膜填料、以及约25重量％至约75重量％的水。

Drugs covered by this patent

Patent Metadata

Patent number: CN113631159A
Jurisdiction: CN
Classification: —
Expires: 2021-11-09
Drug substance claim: No
Drug product claim: No
Assignee: Kedi Biomedical Wuxi Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.